DafinchiAs you may know, we have announced at the end of our clinical program that we have all the clinical data we need to submit, but we do need to gather a little bit more on the CMC side.
LLY2026 Q2Healthcare
1mo
Eli Lilly and Company 2026 Q2: Medicare GLP-1 Bridge program expands obesity access for seniors
Medicare GLP-1 Bridge program expands obesity access for seniors
- Lilly stated the Medicare GLP-1 Bridge program launched July 1 and provides insurance coverage for GLP-1s for obesity at a low out-of-pocket price of $50 per month for 20 million eligible Americans.
- Management said coverage for obesity medicines increased by 35% in the U.S. with the Bridge program.
- They described early feedback as positive from patients and physicians and emphasized working closely with CMS on educating stakeholders and fulfilling criteria.
- In Q&A, management estimated preference for injectables at roughly 80% of treated patients, but also said new patients were ~60% to 70% coming in without prior access.
- They said LillyDirect was enabled to fulfill on the Bridge process and pointed to momentum inflection for Zepbound and Foundayo over the last few weeks.